TABLE 1

Patient Characteristics

CharacteristicData
Age (y)68 (56–81)
Initial Gleason score9 (6–9)
PSA at time of scan (ng/mL)473 (1.7–2,792)
WHO performance score0 (0–2)
Length (cm)181 (171–191)
Weight (kg)92 (64–119)
Prior treatment
 Androgen deprivation therapyn = 7 (88%)
 Docetaxeln = 7 (88%)
 Enzalutamide/abirateronen = 5 (63%)
  • Qualitative data are expressed as numbers followed by percentages in parentheses; continuous data are expressed as median followed by range in parentheses.

  • WHO = World Health Organization.